Sign up online today & collaborate
or click here to find out more
Iselin, NJ, USA and Reading, UK – Indegene (www.indegene.com), a leading global provider of clinical, commercial, and marketing solutions to life science, pharmaceutical, and healthcare organisations and TranScrip (www.transcrip-partners.com), a renowned global provider of innovative scientific support throughout the product lifecycle, today announced the extension of their existing alliance with the launch of IntraScience.
IntraScience covers the full spectrum of business process solutions to clinical, regulatory, safety and medical affairs from early drug development to mature products. It uniquely combines a full range of global operational activities provided by large operational, pharmacovigilance and medical affairs CROs with a solid base of highly experienced big pharma- and biotech-trained therapeutic and functional staff from Europe and the US.
For large pharma clients, IntraScience seamlessly integrates Indegene and TranScrip staff with client teams for highly cost-effective, top quality deliverables. For smaller clients, IntraScience offers comprehensive managed services, such as end-to-end pharmacovigilance/drug safety, throughout product development and lifecycle. For both large and small clients, the service will reduce risk and create value through innovation coming from experienced teams of scientists, physicians, software developers, business development experts and project managers. The flexibility of the IntraScience team allows a responsive customer relationship adding value whether the client is a small biotech with an early development pipeline and no registered products or is one of the top 20 pharma companies with an extensive portfolio of marketed products.
Mr. Manish Gupta, CEO, Indegene, said: “Indegene is excited to set up IntraScience with TranScrip, a uniquely experienced biopharma support organisation. Through this partnership, our highly experienced drug development and medical affairs teams will provide global delivery of end-to-end pharmacovigilance and regulatory services including medical monitoring and call centres across five continents.”
Dr Flic Gabbay, Managing Partner, TranScrip said: “The IntraScience model, where offshoring and nearshoring are combined, will resolve many of the resourcing challenges within big pharma and biotech and bring a more personal touch to this kind of service. We are thrilled to have Indegene as our partner. Our combined value proposition will help address several of the unmet needs of the industry.”